2,4-Dichloro-1-(2-propynyloxy)benzene

We are 2,4-Dichloro-1-(2-propynyloxy)benzene CAS:17061-90-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 17061-90-4
Product Name: 2,4-Dichloro-1-(2-propynyloxy)benzene
Other Name:
2,4-Dichloro-1-(2-propynyloxy)benzene
2,4-dichloro-1-prop-2-ynoxybenzene
 
Density: 1.304g/cm3
Boiling Point: 275.5ºC at 760mmHg
Melting Point: 47-49ºC
Molecular Formula: C9H6Cl2O
Molecular Weight: 201.04900
Flash Point: 117.6ºC
Exact Mass: 199.98000
PSA: 9.23000
LogP: 3.00540
Vapour Pressure: 0.00853mmHg at 25°C
Index of Refraction: 1.559
 
Specification
Appearance: Solid
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Oxadiargyl CAS: 39807-15-3.
Be used as pesticide intermediate, mainly used to synthesize herbicide Oxadiargyl.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2,4-Dichloro-1-(2-propynyloxy)benzene


Related News: At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity.865363-93-5 At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity.ethyl (3S,4R)-4-amino-3-methoxypiperidine-1-carboxylate,hydrochloride Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.108-68-9 The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.

Related Products
Product Name
Triethoxy(2,4,4-trimethylpentyl)silane View Details
3,4-DIMETHOXYBENZOYL CHLORIDE View Details
(2,4-Difluorophenyl)-4-piperidylmethanone Oxime Hydrochloride View Details
(4-Ethoxy-2,3-difluorophenyl)boronic acid manufacturer LINOLEIC ACID SODIUM SALT manufacturer 5-Fluoro-2-methylaniline manufacturer Saikosaponin A manufacturer 2-Chloro-4-iodopyridine manufacturer